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OBJECTIVE—Phosphatidylinositol-4-phosphate-5-kinase (PI4P5K)
has been proposed to facilitate regulated exocytosis and speciﬁ-
cally insulin secretion by generating phosphatidylinositol-4,5-
bisphosphate (PIP2). We sought to examine the role of the a
isoform of PI4P5K in glucohomeostasis and insulin secretion.
RESEARCH DESIGN AND METHODS—The response of
PI4P5Ka
2/2 mice to glucose challenge and a type 2-like diabetes-
inducing high-fat diet was examined in vivo. Glucose-stimulated
responses and PI4P5Ka
2/2 pancreatic islets and b-cells were
characterized in culture.
RESULTS—We show that PI4P5Ka
2/2 mice exhibit increased
ﬁrst-phase insulin release and improved glucose clearance, and re-
sist high-fat diet-induced development of type 2-like diabetes and
obesity. PI4P5Ka
2/2 pancreatic islets cultured in vitro exhibited
decreased numbers of insulin granules docked at the plasma
membrane and released less insulin under quiescent conditions,
but then secreted similar amounts of insulin on glucose stimula-
tion. Stimulation-dependent PIP2 depletion occurred on the plasma
membrane of the PI4P5Ka
2/2 pancreatic b-cells, accompanied by
a near-total loss of cortical F-actin, which was already decreased in
the PI4P5Ka
2/2 b-cells under resting conditions.
CONCLUSIONS—Ourﬁndings suggestthatPI4P5Ka plays a com-
plex role in restricting insulin release from pancreatic b-cells
through helping to maintain plasma membrane PIP2 levels and
integrity of the actin cytoskeleton under both basal and stimula-
tory conditions. The increased ﬁrst-phase glucose-stimulated re-
lease of insulin observed on the normal diet may underlie the
partial protection against the elevated serum glucose and obesity
seen in type 2 diabetes-like model systems. Diabetes 60:454–463,
2011
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ailure of pancreatic b-cells to release adequate
amounts of insulin contributes to the onset of
type 2 diabetes and obesity (1). Elevated serum
glucose transported into pancreatic b-cells is
metabolized to increase cytosolic ATP levels, which then
promote closure of ATP-sensitive K
+ (KATP) channels,
causing membrane depolarization. Membrane depolar-
ization triggers opening of L-type Ca
2+ channels, inﬂux of
Ca
2+, and exocytosis. The ﬁrst phase of exocytosis entails
fusion of primed insulin granules predocked at the plasma
membrane (2). A second phase involving mobilization of
distal insulin vesicles occurs after approximately 10 min
(3), preceded by actin cytoskeletal reorganization (4–6)
and generation of lipid second messengers (7,8). The ma-
jority of type 2 diabetes is only weakly associated with
speciﬁc genetic defects and is characterized by inadequate
release of insulin, in addition to insulin resistance exhibi-
ted by fat and muscle target cells. Prolonged stimulation of
b-cells by elevated levels of glucose, such as is encoun-
tered in the typical western-style high-fat diet, eventually
sufﬁces to trigger changes in insulin secretion in many
individuals with otherwise seemingly normal physiology
and genetics.
Lipid kinases and their phosphoinositide products play
important roles in secretory vesicle trafﬁcking (9). Type I
phosphatidylinositol-4-phosphate-5-kinases (PI4P5Ks) a,
b,a n dg generate the signaling lipid phosphatidylinositol-
4,5-bisphosphate (PIP2). Elegant studies in neurons and
neuroendocrine cells on the role of PI4P5Kg (10,11) and
PIP2 (12–14) have revealed that PIP2 generation at the
plasma membrane is critical during regulated exocytosis.
PIP2 directly facilitates some types of Ca
++ signaling
(15,16), recruits proteins that facilitate the fusion process
(13,14), and is required for docked secretory vesicles to
undergo priming to become part of the ready-releasable
pool and then fuse into the plasma membrane (10,11).
Although less well understood mechanistically, decreased
levels of PIP2 have also been shown to inhibit insulin se-
cretion in pancreatic b-cell model systems (7,17–19).
However, PIP2 also carries out functions that potentially
oppose regulated exocytosis (20). First, PIP2 supports the
open state of the KATP channel (21,22); thus, because it is
ATP-driven closure of the KATP channel that triggers se-
cretion, PIP2 deﬁciency might be anticipated to decrease
K
+ efﬂux, triggering membrane depolarization and thus
increasing Ca
++ currents, resulting in increased secretion
(23–25). In support of this model, expression of a dominant-
negative isoform of PI4P5K to lower levels of PIP2 changes
the responsiveness of mutant KATP channels with decreased
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ORIGINAL ARTICLEATP sensitivity. However, expression of the dominant-
negative PI4P5K does not alter function of wild-type (WT)
KATP channels, suggesting that under normal physiologic
conditions, the level of PIP2 on the plasma membrane is
not high enough to strongly affect KATP channel activity
(26). PIP2 has also been suggested to restrain fusion of
docked vesicles by inhibiting SNARE complex function
(14,27), with the restraint being alleviated through se-
questration of the PIP2 by Syntaxin-1 (14) or Ca
2+-triggered
PIP2 destruction (28).
Taken together, the action of PIP2 is complex, and both
its synthesis and its turnover are required at different steps
in the fusion process.
Another function undertaken by PIP2 is to promote as-
sembly of actin ﬁlaments (F-actin) (29,30). F-actin at the
periphery of the cell (cortical F-actin) has also been pro-
posed to have both positive and negative regulatory
functions in exocytosis. Cortical F-actin has been pro-
posed to act as a barrier to block access of undocked se-
cretory vesicles to the plasma membrane; consistent with
this model, cortical F-actin is disassembled during regu-
latory exocytosis events (31), and pharmacologic agents
that disassemble F-actin enhance movement of insulin
granules to the plasma membrane and insulin release,
whereas agents that stabilize the actin cytoskeleton de-
crease insulin release (4,18,32–34). F-actin may also affect
SNARE complex function by binding to and inhibiting
Syntaxin-4 function in a glucose stimulation-relieved
manner (32,33). To further complicate matters, F-actin can
also undertake a positive role in regulated exocytosis by
mediating translocation of more internal secretory vesicles
to the periphery, particularly in poorly granulated or re-
cently degranulated cells (4,35). Thus, dynamic regulation
of the actin cytoskeleton is also important in the pro-
gression of regulated exocytosis and can play positive or
negative roles depending on the setting.
Changes in PIP2 and cortical F-actin can have positive
and negative effects on the secretory process, making it
difﬁcult a priori to predict the outcomes of their physio-
logic and experimental manipulation. Critically, individual
PI4P5K isoforms may generate subpools of PIP2 that reg-
ulate distinct components of the fusion process. Deletion of
PI4P5Kg markedly decreases levels of PIP2 at the plasma
membrane in resting neurons and neuroendocrine cells,
and inhibits secretion at the stage of vesicle priming and
fusion without notable effect on the actin cytoskeleton
(10,11). In contrast, deletion of PI4P5Ka increases mast
cell degranulation triggered by cross-linking of the IgE re-
ceptor, accompanied by minor decreases in cellular PIP2,
but signiﬁcantly increased levels of Ca
2+ signaling and de-
creased levels of total F-actin (36). PI4P5Ka knockdown
using RNAi has also been reported to alter Ca
2+ signaling,
disrupt F-actin, and affect insulin release in a pancreatic
b-cell line (37).
This report examines insulin secretion in PI4P5Ka
2/2
mice and ﬁnds that ﬁrst-phase insulin release is aug-
mented, and on a high-fat diet, fasting and stimulated se-
rum insulin levels are even more elevated, conferring
faster glucose clearance and resistance to the develop-
ment of obesity. In this setting, K
+ and Ca
++ signaling is
seemingly normal; in contrast, the determinative factor
seems to be a dramatic stimulation-dependent loss of PIP2
at the plasma membrane that leads to reorganization of the
actin cytoskeleton resulting in a near-total loss of cortical
F-actin and decreased numbers of insulin granules docked
at the plasma membrane.
RESEARCH DESIGN AND METHODS
Animals. PI4P5Ka
2/2 male mice backcrossed to C57BL/6 were genotyped per
Sasaki and colleagues (36). Animal experiments were performed in accor-
dance with the rules and regulations of the Stony Brook University Animal
Care Committee. For high-fat diet, 12-week-old mice were switched from
normal chow to 45% high fat (Research Diets, Inc., New Brunswick, NJ) for 8
weeks (38).
Intraperitoneal glucose and insulin tolerance tests. Mice fasted for 14 h
were injected intraperitoneally with 1 g/kg 25% D-glucose in saline. Blood
(5–10 mL) was collected from the tail. Blood glucose was determined by
a glucometer and insulin by ELISA kit (Crystal Chem Inc., Downers Grove, IL).
For insulin tolerance tests, mice were fasted for 6 h before being injected
intraperitoneally with insulin (0.85 units/kg of Novolin R; Novo Nordisk,
Bagsværd, Denmark). Blood glucose levels were monitored as above imme-
diately before injection and at 15, 30, 45, 60, and 90 min after injection.
Isolation of pancreatic islets. Pancreatic tissue from 8-week-old male mice
was dissolved in Hank’s balanced salt solution (HBSS) containing Liberase
(Roche 11815032001) and DNase I (Roche 10104159001) at 37°C for 40–50
min; digestion was stopped with HBSS/10% FBS and two washes with HBSS/
2% FBS. The tissue was passed through a cell strainer and applied to a Poly-
sucrose (Cellgrow 61196RO) gradient of 25, 23, 20, and 11% layers to isolate
the islets that were aspirated from the interfaces between the 11 and 20% and
the 20 and 23% gradients, washed, and picked under a dissecting microscope.
Islets were used immediately or cultured in Roswell Park Memorial Institute
medium/10% FBS, Pen/Strep, and glutamate.
Insulin secretion via static incubation. Pancreatic islets (n = 10) were
incubated in 250 mL of Krebs-Ringer bicarbonate HEPES buffer for 30 min at
37°C, and aliquots were taken as basal samples. The glucose was increased to
20 mmol/L, and the cultures were incubated for another 30 min. Samples were
placed on ice or stored at 220°C. To determine total insulin content, the islets
were dissolved in 70% ethanol and 0.18 mol/L HCl overnight, sonicated, and
centrifuged before samples were taken for analysis using an ultrasensitive
murine insulin ELISA (Mercodia: 10115010) and BioRad plate reader. Total
protein concentrations were determined with a BioRad Bradford protein
assay.
Immunostaining, electron microscopy, and morphologic analysis of
islets. Pancreatic islets were ﬁxed in 4% paraformaldehyde for 20 min and
permeabilized in 0.1% Triton X-100 for 20 min. Immunoﬂuorescence staining
for insulin and glucagon was performed with rabbit anti-insulin (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) and murine anti-glucagon (Sigma, St. Louis,
MO), followed by ﬂuorescein isothiocyanate-conjugated anti-rabbit and Alexa
546-conjugated anti-mouse antibodies (Molecular Probes, Eugene, OR). For
actin cytoskeleton staining, ﬁxed and permeabilized islets were stained with
Rhodamine-phalloidin, and the ﬂuorescence intensity was acquired from the
top to the bottom of the islets using continuous xyz-scan mode on the Leica
confocal microscope. All isletswere scanned atthe samegainintensity,and the
three-dimensional series was assembled using confocal imaging software.
For electron microscopy analysis, islets were incubated in Krebs-Ringer
bicarbonate HEPES buffer containing 2.8 mmol/L glucose at 37°C for 30 min
(nonstimulated islets), and some were further incubated in 20 mmol/L glucose
for 30 min (stimulated islets). The islets were ﬁxed in 2% paraformaldehyde/2%
electron microscopy grade glutaraldehyde in 0.1 mol/L phosphate buffer, pH
7.4 for 15 min, postﬁxed in 2% OsO4 in PBS for 1 h, dehydrated, inﬁltrated, and
embedded in plastic resin. Ultra-thin sections were stained with uranyl acetate
and lead citrate before examination using a FEI BioTwinG
2 transmission
electron microscope (FEI Company, Hillsboro, OR). b-cell size and insulin
granules were analyzed using Image J software (National Institutes of Health;
http://rsb.info.nih.gov/ij/).
Statistics. Results are expressed as mean 6 SD unless otherwise stated in
Figs. 1–7. Statistical differences between datasets were assessed using the
unpaired Student t test.
RESULTS
Enhanced insulin secretion and improved glucose
tolerance in PI4P5Ka
2/2 mice. PI4P5Ka
2/2 (KO) mice
fed on normal mouse chow for 8–12 weeks were visually
indistinguishable from age- and sex-matched WT littermate
mice but weighed signiﬁcantly less (26 vs. 28 g, P = 0.03,
n = 16, Fig. 1A). Glucose tolerance tests revealed that the
fasting serum glucose levels were signiﬁcantly lower in the
KO mice than in the WT mice (86 6 21 mg/dL vs. 126 6 34
mg/dL, respectively) and that the KO mice cleared glucose
faster (Fig. 1B). Serum insulin levels were increased in the
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diabetes.diabetesjournals.org DIABETES, VOL. 60, FEBRUARY 2011 455FIG. 1. PI4P5Ka KO mice exhibit improved glucohomeostasis on normal murine chow and resist development of type 2-like diabetes responses on
a high-fat diet. A: Body weights of WT and KO mice (n = 16) raised on normal murine chow. Age-matched male mice were used for all experiments. B:
Serum glucose levels for WT and KO mice (n = 9) in fasting mice (0 min time point) and after 1 g/kg body mass intraperitoneal injection of 25%
glucose (intraperitoneal glucose tolerance test) (*P < 0.04). C: Serum insulin levels measured in parallel (*P < 0.05; #P < 0.1). D: Insulin tolerance
test performed on WT and KO mice (n =5 ;* P < 0.05). E: Body weights of WT and KO mice (n = 10) after 8 weeks on a high-fat diet. F:I n t r a p e r i t o n e a l
glucose tolerance test results on high-fat diet (*P < 0.03; #P < 0.06). G: Serum insulin levels measured in parallel (*P < 0.05, n = 7). Statistical
signiﬁcance determined by Student t test. Representative of three experiments. ITT, insulin tolerance test; GTT, glucose tolerance test.
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total insulin secretion, calculated as area under the curve,
was signiﬁcantly increased (P , 0.04) from 67.8 6 5.5 ng/
mL/120 min to 76.2 6 6.3 ng/mL/120 min, suggesting a basis
for the improved glucose clearance. An insulin tolerance
test did not reveal increased peripheral glucose utilization
for PI4P5Ka KO mice in comparison with WT mice (Fig. 1D),
ruling out the possibility of increased insulin sensitivity by
target tissues as a mechanism.
PI4P5Ka KO mice resist developing type 2 diabetes-
like symptoms on a high-fat diet. C57BL/6 mice placed
on high-fat diets develop hyperglycemia and obesity (39).
Age- and sex- matched WT and KO mice generated and
maintained on the C57BL/6 background were placed on
high-fat chow for 8 weeks. The mice exhibited a sub-
stantial gain in weight in comparison with mice on normal
chow (Fig. 1E vs. Fig. 1A). However, the PI4P5Ka KO mice
gained 30% less weight than the WT mice (Fig. 1E). Fasting
serum glucose levels were elevated in both the WT and
PI4P5Ka KO mice, although the levels remained higher in
the WT mice (Fig. 1F). Moreover, whereas WT mice
exhibited prolonged and higher elevation of serum glucose
levels, the PI4P5Ka KO mice exhibited a more rapid return
to euglycemia (Fig. 1F). Fasting and stimulated serum in-
sulin levels were elevated in the WT mice (Fig. 1G).
However, insulin levels in the PI4P5Ka KO mice were even
further elevated under fasting (3.01 6 0.40 vs. 1.59 6 0.44
ng/mL for the WT mice, P , 0.05) and glucose-stimulated
conditions.
By using the hyperglycemic clamp technique, glucose
levels were clamped at $250 mg/dL (Fig. 2A) and insulin
levels were measured at frequent intervals. Elevated
FIG. 2. First-phase GSIR and L-arginine potentiation are increased in absence of PI4P5Ka. A: WT and KO mice received a bolus of 20% glucose to
increase serum glucose levels >250 mg/dL and were then maintained at that level by intravenous infusion adjusted for the change in serum glucose
levels over time. B: Insulin secretion during the hyperglycemic clamp. Blood samples were taken at the intervals shown and assayed for serum
insulin levels. At min 80, a bolus of 20% L-arginine and then an L-arginine infusion were added. Each experiment group was composed of four age-
matched male mice. *Signiﬁcant P values as indicated. Statistical signiﬁcance determined by Student t test.
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5 min after the start of the glucose infusion (Fig. 2B), but
the levels of release were subsequently similar to those of
WT mice. Addition of L-arginine, a potentiator of glucose-
stimulated insulin release (GSIR), resulted in increased
insulin release in both WT and KO mice, but the effect was
substantially greater for the KO mice.
Taken together with the results shown in Fig. 1, these
ﬁndings suggest that deletion of the PI4P5Ka gene results
in increased ﬁrst-phase glucose-dependent insulin secre-
tion that counters the development of the type 2 diabetic-
like phenotype.
Plasma membrane PIP2 is not maintained in KO islets
on stimulation. The availability of PIP2 at the plasma
membrane plays critical roles in many cell signaling pro-
cesses (40). Total cellular PIP2 levels in cells from
PI4P5Ka KO mice were examined previously (36) and
found to be decreased only modestly (90% of WT levels).
However, PIP2 exhibits rapid turnover and resynthesis at
the plasma membrane on glucose-triggered b-cell stimu-
lation as a consequence of Ca
2+-mediated phospholipase C
activation (28). The signaling pathway leading to PIP2
turnover can also be initiated by elevating levels of ex-
tracellular K
+ to depolarize the b-cell, thereby triggering
the same downstream effects (18). We used this approach
to examine whether there were differences in basal or
stimulated levels of accessible PIP2 at the plasma membrane
of isolated pancreatic b-cells as reported by a ﬂuorescent
PIP2 sensor based on fusion of EGFP to the PIP2-binding
PH domain of PLCd1( P L C d1-PH-EGFP). Primary pan-
creatic b-cells were transfected in vitro with a reporter
plasmid expressing PLCd1-PH-EGFP, with a transfection
frequency of 80–85% (Supplementary Fig. 1). Under basal
conditions, PIP2 was readily imaged at the plasma mem-
brane in both the WT and KO cells (Fig. 3A, rows 1 and 3),
although it should be noted that this observation demon-
strates only that the minimal threshold for sensor re-
cruitment is in place, not necessarily that the levels of
accessible plasma membrane PIP2 are quantitatively iden-
tical. However, differences were observed on K
+-elicited
depolarization. Whereas no change was observed for WT
b-cells, indicating that the rates of resynthesis of PIP2
compensated for the depolarization-triggered turnover,
relocalization of the sensor from the plasma membrane to
the cytoplasm was observed for the PI4P5Ka KO cells. A
mutant sensor, PLCd1-R40L-PH-EGFP, which lacks the ca-
pability to bind PIP2, distributed uniformly in the cytoplasm
under both basal and stimulated conditions (Fig. 3B). There
were no obvious changes in localization of the insulin
FIG. 3. Plasma membrane PIP2 is not maintained in KO b-cells on de-
polarization. A: b-cells isolated from WT and KO islets were transfected
with a plasmid expressing the PIP2 sensor PLCd1-PH-EGFP, cultured
for 2 days, depolarized with extracellular K
+ for 5 min, ﬁxed, and im-
aged using confocal microscopy. Pancreatic b-cells were identiﬁed us-
ing an anti-insulin antibody in combination with a red ﬂuorescent
secondary antibody. B:K Ob-cells expressing a mutant PIP2 sensor
(PLCd1-PH-R40L-EGFP) that does not exhibit PIP2 binding activity
were processed as in A. Images were taken through the midpoints of the
cells and are representative of the typical transfected, insulin-positive
cells observed in the experiments (n > 100). The experiment was re-
peated at least three times using two animals each time (n = six mice),
and similar outcomes were obtained. Greater than 90% of the cells
examined responded as shown in the images in each condition. (A high-
quality color representation of this ﬁgure is available in the online issue.)
FIG. 4. PI4P5Ka KO islets secrete insulin with altered kinetics on
glucose stimulation. WT and KO islets (10 islets per experimental
sample, experiment performed six times) were isolated from age- and
sex-matched mice, preincubated in nonstimulatory culture media (2.8
mmol/L glucose), and challenged with 20 mmol/L glucose. Six mice were
used for each genotype. Incubation times were 30 min in succession for
each condition. Stimulated insulin release is presented after sub-
traction of the basal release. Data are presented as mean 6 SEM.
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stimulated conditions in comparison with the WT cells.
These results indicate that plasma membrane PIP2 de-
creases after depolarization (stimulation) of the PI4P5Ka
KO b-cells, but because of a reduced capacity for resyn-
thesis, the recovery of PIP2 levels at the plasma membrane
is blunted.
PI4P5Ka KO islets exhibit alterations in ex vivo
insulin secretion. Surprisingly, release of insulin by
PI4P5Ka KO islets cultured ex vivo was signiﬁcantly less
under basal conditions, but similar to WT on glucose
stimulation (Fig. 4). We measured the total insulin content
per islet (112 ng/islet, WT, vs. 94 ng/islet, KO; NS), exam-
ined islet appearance using anti-insulin and glucagon
immunostaining to visualize b- and a-cells, respectively
(Fig. 5A), and examined b-cell morphology by electron
microscopy (Fig. 5D) to estimate b-cell size (Fig. 5B) and
the number of insulin granules per cell (Fig. 5C). No sig-
niﬁcant differences were found between the WT and
PI4P5Ka KO islets for any of these parameters. We also
used quantitative RT-PCR to examine expression levels
for the other two PI4P5K isoforms, b and g,b u td i d
not observe compensatory upregulation (Supplementary
Fig. 2). However, quantitative analysis of the subcellular
distribution of insulin granules by electron microscopy
(41,42) revealed that decreased numbers of granules were
docked at the plasma membrane in the PI4P5Ka KO cells
(i.e., were localized within 50 nm of the plasma mem-
brane) (Fig. 5D and E), suggesting a basis for the decrease
in basal insulin secretion in KO mice in the ex vivo ex-
periments. On glucose stimulation, the number of granules
localized at 50–300 nm from the plasma membrane de-
creased in both WT and KO b-cells, whereas the number
of granules localized within 50 nm of the plasma mem-
brane increased; no signiﬁcant differences were seen at
that point between WT and KO b-cells for insulin granule
distribution within 50 nm of the plasma membrane, in-
dicating that the readily releasable pool was rapidly
replenished once the glucose stimulatory pathway had
been activated.
WT and KO islets exhibit comparable K
+ and Ca
++
signaling on b-cell stimulation. Key steps in the glucose-
stimulated insulin secretion pathway involve KATP channel
closing and membrane depolarization that triggers increased
intracellular Ca
2+, and disassembly of cortical F-actin, all of
w h i c hc o u l db er e g u l a t e db yP I P 2 availability. To examine
FIG. 5. Morphology of islets, b-cell size, and insulin granule density are not noticeably different in PI4P5Ka KO mice, but distance of granules from
cortex is. A: Confocal microscopy image of WT and KO islets stained with anti-insulin and antiglucagon primary antibodies to visualize b-cells and
a-cells, respectively. B: Quantitation of WT and KO b-cell size using transmission electron microscopy. C: Quantitation of the number of insulin
granules contained in WT and KO islets normalized for the size of the each islet. D: Transmission electron microscopy images of WT and KO islets.
KO b-cells show less insulin vesicles docked at the plasma membrane in comparison with WT b-cells (magniﬁed lower panels; bar, 500 nm).
Asterisks indicate boundaries between adjacent b-cells. E: Distance of subgranular pools of insulin to the plasma membrane in WT and KO cells
under basal conditions. Insulin granules were grouped into three categories with respect to distance from plasma membrane: <50, 50–300, and
>300 nm. Granules located with 50 nm from plasma membrane were considered to be docked granules. Granules were tabulated from 10 sections
for each genotype. Data are presented as mean 6 SEM. (A high-quality color representation of this ﬁgure is available in the online issue.)
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triggered insulin secretion, we bypassed the channel closing
step using elevated extracellular K
+ to directly depolarize the
cells. As with glucose stimulation, the PI4P5Ka KO islets
exhibited lower levels of insulin release under basal con-
ditions, and then levels of release on depolarization that
were similar to that observed for the WT islets (Fig. 6A). We
also performed patch clamping on isolated b-cells to exam-
ine KATP channel inactivation, but no differences were
noted between WT and PI4P5Ka KO cells (data not shown).
These results suggested that the step affected by the loss of
PI4P5Ka-generated PIP2 lies downstream of KATP channel
depolarization. We next measured intracellular Ca
2+ levels in
both WT and KO islets on glucose stimulation, but did not
observe signiﬁcant differences between the genotypes on
glucose stimulation (Fig. 6B). Taken together, these ﬁndings
indicate that the metabolic signaling pathway that proceeds
from glucose import to increased intracellular Ca
2+ is normal
in PI4P5Ka KO b-cells.
F-actin organization is diminished at the cell cortex
membrane of PI4P5Ka KO islets. Under basal con-
ditions, most of the F-actin in WT b-cells localized to the
plasma membrane (Fig. 7A). However, in PI4P5Ka KO
b-cells, the amount of cortical F-actin was greatly di-
minished, with much of the residual ﬂuorescence appear-
ing diffuse or relocalized to internal sites suggestive of
vesicles or stress ﬁbers (Fig. 7A). On glucose stimulation
for 5 min, much of the cortical F-actin in the WT b-cells
was disassembled, with relocalization to stress ﬁbers
noted in some cells (Fig. 7B); in contrast, F-actin was
virtually completely absent in glucose-stimulated PI4P5Ka
KO b-cells. Quantitation of the F-actin ﬂuorescence
revealed a 60% decrease in the PI4P5Ka KO cells in com-
parison with WT islets under basal conditions and an 80%
decrease after stimulation with glucose for 5 min (Fig. 7C).
No difference in total actin in the KO cells was observed
(Fig. 7D).
DISCUSSION
Both positive and negative roles have been described for
PIP2 and the actin-cytoskeleton network in regulation of
exocytosis and in particular insulin secretion. PIP2 is re-
quired for vesicle fusion at the plasma membrane (10,11),
but also inhibits SNARE complex-mediated fusion (14) and
facilitates KATP channel activity (21–23), which opposes
FIG. 6. PI4P5Ka KO islets secrete insulin with altered kinetics on K
+ depolarization and display comparable Ca
2+ inﬂux on glucose stimulation. A:
WT and KO islets (10 islets per experimental sample, experiment was performed nine times) were isolated from age- and sex-matched mice,
preincubated in nonstimulatory culture media (2.8 mmol/L glucose), and challenged with 60 mmol/L K
+. Incubation times were 30 min in succession
for each condition. Stimulated insulin release is presented after subtraction of the basal release. Data are presented as mean 6 SEM. B:C a
2+ inﬂux
was measured by ﬂuorescent quantiﬁcation in WT and KO islets before and after glucose stimulation. The cytosolic Ca
2+ concentration was
measured using Fluo-4 dye, and the relative intensity change (F-F0)/F0 vs. time was plotted, where F0 and F stand for resting ﬂuorescence and
ﬂuorescence after 20 mmol/L glucose stimulation, respectively. Traces of individual islets representative of three experiments are shown.
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prevents secretory vesicle access to the plasma membrane
(18,31,43) and inhibits SNARE complex-mediated fusion
(33), but it also promotes movement of secretory granules
to the plasma membrane from regions deeper in the cell
(4). In summary, both turnover (14,18,20,28) and synthesis
(7,10,11,13,14,17–19) of PIP2 are required at different steps
in the secretory process, and dynamic reorganization of
FIG. 7. PI4P5Ka KO islets exhibit a dramatic deﬁciency in cortical F-actin under both basal and stimulated conditions. WT and KO islets were
stained for F-actin using rhodamine-phalloidin before (A) and after (B) glucose stimulation for 5 min and ﬁxation. Pancreatic b-cells were vi-
sualized using anti-insulin primary antibody with confocal microscopy. Shown are individual optical sections. Compiled sets of the optical sections
are presented in the Supplementary Data. Scare bar, 50 mm. C: Quantiﬁcation of F-actin ﬂuorescence. Fluorescence intensity was acquired from
the top to the bottom of the islets using continuous xyz-scan mode on the Leica confocal microscope. All islets were scanned at the same gain
intensity, and the three-dimensional series was assembled using the confocal imaging software. Total ﬂuorescence intensity was determined for 10
islets, and average ﬂuorescence and standard deviation were determined. **P < 0.01. D: Western blot for actin from lysates of WT and KO cells,
representative of four experiments. (A high-quality color representation of this ﬁgure is available in the online issue.)
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way that this is achieved is through the use of different
PIPK isoforms; PI4P5Kg and the type 2 PIP2-synthesizing
enzyme, PI5P4Kb, generate a pool of PIP2 required for
vesicle fusion in neurons and pancreatic b-cells (7,10,11,19)
that does not substantially regulate the actin cytoskeleton.
In contrast, PI4P5Ka appears to generate a pool of PIP2
that inhibits exocytosis in mast cells, potentially through
stabilizing F-actin (36). Plasma membrane PIP2 exists in
microdomains, some of which colocalize with syntaxin
and promotes exocytosis (44), and others which coloc-
alize with lipid rafts and regulate cortical actin assembly
(44,45). PI5P4Kb colocalizes with and regulates the syn-
taxin-associated PIP2 microdomains (44); it is possible
that PI4P5Ka may localize and regulate the lipid-raft as-
sociated PIP2 microdomains.
This study reports alterations in insulin release by pan-
creatic b-cells in mice lacking PI4P5Ka. The KO mice ex-
hibit increased ﬁrst-phase insulin secretion and improved
glucose clearance under normal diet chow, and elevated
insulin under fasting and GSIR conditions on a high-fat
diet. Changes in K
+ and Ca
++ signaling were not observed,
which is consistent with the report that under normal
physiologic conditions, the level of PIP2 on the plasma
membrane is not high enough to strongly affect KATP
channel activity (26), and thus decreasing it via ablation of
PI4P5Ka has no effect on glucose-stimulated changes in
K
+ currents. In contrast, a dramatic decrease of cortical
F-actin was observed, accompanied by decreased numbers
of insulin granules docked at the plasma membrane and
less insulin secretion under basal ex vivo conditions.
Unexpectedly differing results were observed between
the in vivo and ex vivo GSIR model systems. Multiple
reasons may underlie the ﬁndings, but we would suggest
that differences in the assay conditions could be the major
factor. Normal physiology involves serum glucose levels in
mice of ;120 mg/dL, or 6.6 mmol/L glucose, which is
a modestly stimulatory level under ex vivo conditions. In
the ex vivo assay, however, islets were placed in low
glucose, 2.8 mmol/L, or ;50 mg/dL, a nonstimulatory
condition, before assaying basal insulin release. It is likely
that under “basal” conditions in vivo (6.6 mmol/L glucose),
a low chronic level of b-cell stimulation leads to continued
transport of insulin granules to the plasma membrane. In
pancreatic b-cells from PI4P5Ka KO mice with diminished
cortical F-actin, the barriers to fusion are decreased, and
exocytosis rapidly occurs, leading to elevated insulin re-
lease, sustained by the continued replacement of the
granules via microtubule transport. This low-level, chronic
release of insulin on ad lib normal chow could account for
the decreased serum glucose levels observed, although
insulin levels were not signiﬁcantly increased under fasting
conditions. Under high-fat diet conditions, insulin levels
were increased under fasting conditions in mutants, pre-
sumably reﬂecting the elevated serum glucose that pro-
vides a greater chronic stimulation to the b-cells. In the ex
vivo setting (2.8 mmol/L), however, the lower level of
b-cell stimulation may fail to sufﬁce to promote the gran-
ule transport, leading to decreased release once the
cortical population of granules has been sufﬁciently di-
minished, as suggested by our morphologic analysis. On
elevated glucose stimulation, however, transport resumes,
leading to similar levels of insulin release as barriers to
fusion are decreased in the WT pancreatic b-cells as well.
The increased ﬁrst-phase in vivo release may also suggest
that granule transport to the plasma membrane or some
other step in the distal part of the process is facilitated in
the KO cells.
Regardless of the precise mechanistic relationship be-
tween insulin secretion and cortical F-actin, the relatively
subtle changes in insulin secretion seem to have a sub-
stantial effect on the obesity and hyperglycemia in the
C57BL/6 high-fat animal model. We would suggest that the
elevated ﬁrst-phase release of insulin leads to a more rapid
return to euglycemia under conditions of exaggerated
nutrient uptake, decreasing the prolonged stimulation of
b-cells that is associated with eventual aberrant signaling,
blunted insulin release, and cell death. It should be noted
that glucose homeostasis is a complex physiologic pro-
cess. b-cells and GSIR play a central role in the process,
but other hormones and the liver, muscle, and adipose
tissue are also involved. It is possible that some of these
other physiologic processes might contribute to the phe-
notype we observed. High-fat murine models are not nec-
essarily predictive of outcomes for type 2 diabetes in
humans, but this work suggests the idea that development
of therapeutics that increase early release of insulin as
described in this report might be valuable as adjuncts for
current therapies targeted toward increasing insulin re-
lease over prolonged periods of time or toward improving
peripheral glucose utilization, because both of the latter
are associated with the side effects characteristic of ex-
cess insulin action on nondesired target tissues, such as
smooth muscle vesicular endothelium, which undergoes
hypertrophy leading to hypertension and vascular disease.
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